Kong, Deguang
Zhou, Hengbo
Neelakantan, Deepika http://orcid.org/0000-0002-3885-3418
Hughes, Connor J.
Hsu, Jessica Y.
Srinivasan, Ramakrishnan Rajaram
Lewis, Michael T.
Ford, Heide L. http://orcid.org/0000-0002-2860-9841
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA224867, F99CA234940, P30CA046934)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | National Institutes of Health (F99CA234940)
Article History
Received: 10 November 2019
Revised: 7 October 2020
Accepted: 22 October 2020
First Online: 9 December 2020
Compliance with ethical standards
:
: MTL is a Founder and Limited Partner in StemMed Ltd, and a Founder and Manager in StemMed Holdings, its General Partner. He is also a Founder and equity stake holder in Tvardi Therapeutics Inc. The remaining authors do not have any conflicts of interest.